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Molecular Analysis of 9p Deletions Associated with
XY Sex Reversal: Refining the Localization of a Sex-
Determining Gene to the Tip of the Chromosome
To the Editor:
Mammalian sexual development is dependent on chro-
mosomal constitution. The Y chromosome acts as a
dominant inducer of testis formation. The choice be-
tween testis and ovary equates with the choice of male
or female development (sex determination). The differ-
entiation of internal and external genitalia and second-
ary characteristics are regulated by endocrine functions
associated with the gonads (sex differentiation). Any de-
fect along the male and female pathway can result in
inconsistencies between karyotypic and phenotypic sex
(sex reversal) (Ford et al. 1959; Jacobs and Strong 1959;
Jost et al. 1973).
The molecular-genetic analysis of primary (gonadal)
sex-reversal syndromes has led to the identification of
several sex-determining genes: SRY, the only Y-linked
gene needed for testis formation; DSS, the X-linked dos-
age-sensitive sex-reversal locus; and the campomelic dys-
plasia (CD) gene SOX9. Functional studies performed
in the mouse have identified other genes involved in go-
nadogenesis, such as the Wilms tumor gene WT-1, and
the gene encoding for the steroidogenic factor 1 SF-1
(reviewed by Schafer and Goodfellow 1996). The genes
identified to date cannot account for all the sex-reversal
cases found in the literature. The reports of both familial
forms of gonadal dysgenesis and sporadic forms asso-
ciated with autosomal anomalies implicate the existence
of other loci (Schafer and Goodfellow 1996). Male-to-
female primary sex reversal has been reported in patients
with terminal deletions of the short arm of chromosome
9: unbalanced translocations and terminal deletions in
which breakpoints range from 9p21 to 9p24 (Bennett
et al. 1993; Begleiter et al. 1995; McDonald et al. 1997;
Ogata et al. 1997; Veitia et al. 1997) (MIM 273350).
The patients have normal female or ambiguous external
genitalia and varying grades of mixed gonadal dysge-
nesis, ranging from fibrous streak gonads associated
with Wolffian duct remnants to immature hypoplastic
testicles. The lack of a correlation between the size of
the deletions and the degree of impaired male devel-
opment excludes the possibility that the deletion has a
position effect on the differentiation of the sexual phe-
notype. It is likely that the interval in the 9p24 region
deleted in all patients contains gene(s) involved in the
differentiation of the male phenotype.
To better define the chromosome 9 region associated
with sex reversal, we have performed a deletion-map-
ping analysis, by looking for the loss of heterozygosity
in a panel of sex-reversed patients with translocations/
deletions of chromosome 9p. This study involves four
patients (SV, B, RB, and TO) who previously had been
reported in the literature (Hoo et al. 1989; Bennett et
al. 1993; Begleiter et al. 1995; Ogata et al. 1997) and
an additional case (GG). These individuals are mono-
somic for varying segments of the chromosome 9 short
arm. The extent of the sex reversal is variable among
them, ranging from an ambiguous intersex to a nearly
complete female phenotype. Karyotypes and clinical de-
tails are summarized in table 1.
The extent of the 9p deletions in the sex-reversed pa-
tients was analyzed by the typing of 20 microsatellite
markers localized to an interval of 27.1 cM in 9p23-
9pter. The heterozygosity of the markers tested is 170%.
Their relative order on the chromosome was derived
from an integrated map of 9p23-9pter, which combines
genetic-mapping data on the above-mentioned loci with
radiation hybrid–mapping data (fig. 1) (Bouzyk et al.
1996; Dib et al. 1996).
Loss of heterozygosity at the microsatellite loci was
scored as potential loss of one allele. For patients TO,
GG, and SV, it was possible to genotype the parents.
This allowed the ascertainment of true hemizygosity for
some of the markers tested. The results from this analysis
are summarized in table 2. The microsatellite analysis
allowed us to determine the potential maximum size of
all the deletions but did not give any information on the
minimum size of the deletions in patients RB, B, and SV.
In the case of SV, the haplotype analysis of the parents’
DNA for the potentially deleted markers was not infor-
mative. In the case of RB and B, parental DNA was not
available. To better define the breakpoints in patients
SV, RB, and B, FISH analysis also was performed, with
genomic clones from 9p24 (for details, see the legend to
fig. 1). All the results obtained from microsatellite typing
and the FISH experiments were analyzed in relation to
the integrated map of 9p23-9pter and were converted
into a map that represents the maximum deletions po-
tentially present in each patient (fig. 1, bars on right
side):
Patient GG.—The maximum deletion extends from
the telomere to D9S256-D9S269. The proximal break-
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Table 1
Karyotype and Clinical Features of the 9p Patients Studied
SV RB B TO GG
Karyotype 46,XY,(9),der(9)
t(7;9)(q21.1;p24),
maternal
46,XY,9,der(9)
t(2;9)(p11;p24), de
novo
46,XY,del(9)
(p23.05), de
novo
46,XY,del(9)
(p23;p24.3), de
novo
46,XY,del(9)
(p23), de novo
External genitalia Ambiguous Female Female Ambiguous Ambiguous
Wolffian structures Unknown Unknown Epididymes,
Wolffian duct
remnants
Epididymes, vasa
deferentia
Rudimentary
vasa deferentia
on the right,
normal on the
left
Mu¨llerian structures Rudimentary uterus Uterus Uterus, fallopian
tubes
Unknown Fallopian tubes
on the right
side
Gonads Testes-like gonads, no his-
tology data
Bilateral gonads, no
biopsy
Streak gonads Hypoplastic testes Small immature
right testis,
normal left
testis
Table 2
Summary of Results Obtained by Typing
Microsatellites from 9p24, on DNA from
SV, RB, B, TO, and GG
MARKER
NO. OF ALLELESa
SV RB B TO GG
D9S1779 1 1 1 1b 1b
D9S1858 1 1 1 1 1
D9S129 1 1 1 1 1b
D9S143 2 1 1 1 1
D9S54 2 1 1 1b 1
D9S1871 2 1 1 1b 1
D9S178 1 1 1 1b 1
D9S288 2 1 1 1b 1b
D9S132 2 1 1 1b 1
D9S1810 2 2 1 1 1
D9S1852 ND 1 1 1 1b
D9S281 2 2 1 1b 1b
D9S286 1 2 1 1b 1b
D9S144 ND 2 1 1b ND
D9S168 2 2 2 2 1
D9S256 2 2 2 1 2
D9S269 2 2 2 1 1
D9S267 2 2 2 1 2
D9S268 1 2 1 2 2
D9S274 2 1 1 2 1
a ND  no data.
b Confirmed hemizygosity.
point lies in a region of 6 cM, between D9S286 and
D9S256-D9S269.
Patient TO.—The maximum deletion extends from
the telomere to D9S168. The haplotype analysis of the
parents’ DNA enabled us to refine the localization of
the proximal boundary to a region of 2.4 cM, between
D9S144 and D9S168.
Patient B.—The maximum deletion extends from the
telomere to D9S168. FISH analysis with probe 4 allowed
us to refine the proximal breakpoint to a region of 10
cM, between D9S1810 and D9S168. An additional FISH
probe (probe 1) was used on metaphase spreads from
B, to assess presence or absence of the most terminal
microsatellite marker. The patient was found to have
one copy deleted.
Patient RB.—The maximum deletion extends from
the telomere to D9S1810. FISH analysis with probe 3
allowed us to refine the proximal breakpoint to a region
of 2 cM, between D9S288/D9S178 and D9S1810.
Patient SV.—The maximum deletion extends from the
telomere to D9S143. FISH analysis with probe 2 con-
firmed the localization of the breakpoint to a region of
1.9 cM, between D9S129 and D9S143.
The haplotype analysis of the typing data shows that
SV, TO, and GG have lost the paternally derived alleles.
Although it was not possible to verify whether all the
deletions are terminal or interstitial, the FISH data to-
gether with the microsatellite data show that all the de-
letions extend at least up to the most telomeric marker
D9S1779.
The correlation between the portion of 9p that is de-
leted and the phenotypic sex of the five patients defines
the minimum region deleted in all the patients as being
the 9p sex-reversal interval critical for male sexual de-
velopment. This region extends from a distal boundary
located between the telomere and D9S1779 to a prox-
imal boundary located between D9S129 and D9S143.
The size of this interval, on the integrated map, is 3–5
cM. This result, compatible with all the molecular data
published to date on 9p deletions associated with sex
reversal, supports the evidence for the localization of a
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Figure 1 Maximum potential deletions in the XY sex-reversed
patients under study, on the basis of results from microsatellite typing
and FISH analysis. The data have been analyzed in relation to an
integrated map of chromosome 9p24. This map contains the micro-
satellite loci studied and has been derived from the integration of the
Ge´ne´thon genetic map, as a framework map (Dib et al. 1996), with
markers from radiation-hybrid mapping (Bouzyk et al. 1996). The
primer sequences for microsatellite typing were obtained from Genome
Database and the Ge´ne´thon World Wide Web pages. The maximum
deletions are represented by the bars on the right side of the integrated
map: the portions confirmed as truly deleted are black; the portions
potentially deleted but not confirmed are horizontally hatched. The
bars on the left side of the integrated map represent the genomic clones
used as probes in the FISH experiments. Their localization has been
deduced on the basis of their marker content. FISH experiments were
as follows: probe 1 tested on patient B, probe 2 on patient SV, probe
3 on patient RB, and probe 4 on patient B. All probes were found
deleted of one copy in the patients tested. Probe codes are as follows:
1  PAC clone LLNLP704K1593Q13, 2  CEPH YAC 798B10, 3
 cosmid clone LL09NC01-304d5, and 4  CEPH YAC 763G5).
putative sex-determining gene to the tip of chromosome
9p. Moreover, our data refine the chromosomal assign-
ment of the putative 9p “sex-reversal” gene, significantly
narrowing the critical interval, from ∼21 cM (D9S144-
9pter) (Veitia et al. 1997) to 3–5 cM (D9S143-9pter;
present study). This region is perhaps too large for any
attempt to clone the gene directly, but it does provide
an excellent starting point for a search, by microsatellite
typing and Southern blot/dosage analysis, for microde-
letions in 46,XY sex-reversed patients with a normal
SRY gene. Additionally, the availability of detailed phys-
ical maps of all of the human genome makes the cloning
of a 3–5-Mb region in YAC contigs quite feasible. This
will allow the exploitation of the huge amount of ex-
pressed sequence tags (ESTs) data now available. Testing
the genes/ESTs grossly mapped in 9p23-9p24, for pres-
ence/absence inside the deletion, can provide a prelim-
inary screen for potential candidate genes. For example,
it has been demonstrated recently that a Caenorhabditis
elegans homologue of the Drosophila melanogaster gene
doublesex is implicated in sexual development in the
worm (Raymond et al. 1998). A human EST homologue
to both the D. melanogaster and C. elegans doublesex
gene has been mapped to chromosome 9p24 (Raymond
et al. 1998). The gene is contained within the minimum
deletion defined in the present study (data not shown),
making it an obvious candidate to test further for a role
in sex determination and differentiation.
All the 9p monosomies associated with sex reversal
that have been described so far have an XY karyotype
and variable differentiation of the sexual phenotype.
Histological examination of the gonads, which has been
performed in a few cases, has revealed the presence of
complete or mixed gonadal dysgenesis, suggesting de-
fective testis development (Bennett et al. 1993; Mc-
Donald et al. 1997; Ogata et al. 1997; Veitia et al. 1997).
The consequent deficiency of the Mu¨llerian inhibiting
substance (MIS) and testosterone produced by the testis
at the crucial time of sexual differentiation would then
be responsible for the defective differentiation of internal
and external genitalia. Moreover, sex reversal is not a
constant feature of the 9p-XY patients (Huret et al.
1988). It has been proposed that the aberrant sexual
phenotype is a recessive character and that the deletion
uncovers a mutated allele on the karyotypically normal
chromosome. In this case, the variable expression of the
sexual phenotype of 46,XY individuals may result pri-
marily from factors other than the mutations, such as
differences in genetic background. Alternatively, sex re-
versal could be the result of a dominant effect of the
deletion causing haploinsufficiency for a gene(s) with
variable penetrance. The latter hypothesis is more likely.
A wide variation of phenotypes, similar to that seen in
these patients, is often found in systems, such as sex
determination, that are subject to dosage sensitivity. In
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human, for example, DSS causes male-to-female sex re-
versal, with varying degrees of masculinization, when
present in two copies in 46,XY individuals (Bardoni et
al. 1994). SOX9 heterozygous loss-of-function muta-
tions cause campomelic dysplasia and lead to sex re-
versal in two-thirds of the 46,XY individuals (Kwok et
al. 1995; Meyer et al. 1997). Cloning of the putative
gene will answer these questions.
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